HSIC (Henry Schein, Inc.) — AI Stock Analysis & Recommendation
Research of September 22, 2026 · Healthcare / Wholesale-Medical, Dental & Hospital Equipment & Supplies
TradeFlare's AI research teams rate HSIC a BUY. The latest price is $85.03.
The research plan
- Entry: $87.43
- Target: $91.80
- Stop: $81.31
- Time horizon: weeks
The fundamental and sentiment teams are bullish, suggesting a medium-term upward trend.
Why
HSIC presents a compelling BUY opportunity driven by strong fundamental and sentiment signals, despite a neutral technical outlook. The recent workforce reduction announcement, coupled with robust revenue and earnings growth, points to potential margin expansion and undervaluation. While technicals are neutral, the risk-reward profile at current levels, with a 7.0% stop-loss and a target just above immediate resistance, warrants a position.
What could push HSIC higher
- Workforce reduction announcement signals potential cost discipline and margin expansion.
- Strong revenue and accelerating earnings growth indicate operational improvements.
- Dominant market share in the U.S. dental distribution market with high switching costs.
Key risks for HSIC
- Recent cybersecurity incidents have disrupted operations and impacted financial results.
- Dependence on a limited number of top suppliers creates vulnerability.
- Performance is sensitive to broader macroeconomic factors impacting healthcare spending.
What each AI research team found
Fundamental team: Bullish · valuation: undervalued
Henry Schein is fundamentally undervalued based on its strong growth prospects, dominant market position, and attractive forward P/E. The company's ability to generate robust free cash flow and positive analyst sentiment further supports a bullish outlook, with a clear path to the analyst consensus target price.
- Forward P/E of 14.58 is significantly lower than trailing P/E of 25.49, indicating expected earnings growth and potential undervaluation.
- Strong revenue growth (6.7% YoY) and accelerating earnings growth (17.1% YoY) demonstrate operational improvements and margin expansion potential.
- Dominant market share (35-40%) in the U.S. dental distribution market with high switching costs from integrated technology solutions creates a strong competitive moat.
Technical team: Neutral
The technical analysis indicates a neutral stance due to conflicting signals and a lack of strong conviction across all indicators. While the workforce reduction news could be a bullish catalyst, current price action and indicators suggest consolidation and a potential near-term pullback towards support at $83.39.
- The price is consolidating between support at $86.79 and resistance at $89.73, with bearish moving average signals (MA20 below MA50) suggesting potential downside.
- Volume has been generally below the 20-day moving average, indicating a lack of strong conviction, with mixed recent volume bars and no clear trend.
- Momentum indicators are mixed, with RSI neutral, MACD showing weakening upward momentum, and Stochastic in the mid-range, suggesting a cautious approach.
Sentiment team: Bullish
The overall sentiment for Henry Schein (HSIC) is strongly bullish, supported by a consensus 'Buy' rating from analysts, positive news flow regarding growth initiatives and financial health, and favorable institutional positioning. While some macroeconomic headwinds and valuation questions exist, the weight of evidence points towards improving sentiment and potential upside.
- Predominantly bullish sentiment driven by recent upgrades, recognition as a growth stock, and positive business developments, despite some cautious notes on valuation
- Positive sentiment driven by strong earnings, favorable analyst ratings, and strategic growth initiatives, with concerns primarily stemming from broader macroeconomic factors
- Strong positive sentiment driven by a predominantly 'Buy' analyst consensus, recent upgrades, and bullish institutional positioning, supported by news highlighting growth and attractive valuation. Consensus: Predominantly 'Buy'.
Risk team: Medium
Henry Schein Inc. presents a medium risk profile, primarily driven by significant cybersecurity concerns and supply chain dependencies. While layoffs suggest cost discipline, the immediate operational impact of cyber incidents and leverage warrant careful consideration.
- Cybersecurity Incidents: Recent cybersecurity incidents have significantly disrupted operations and impacted financial results, posing a substantial threat to business continuity and data integrity.
- Supply Chain Dependence: Reliance on a limited number of top suppliers creates vulnerability to disruptions and price fluctuations.
- Macroeconomic Sensitivity: The company's performance is influenced by broader economic factors impacting healthcare spending.
HSIC at a glance
| Market value | $9.5B |
| Price / earnings | 24.6 |
| Revenue growth (year over year) | 6.5% |
| Profit margin | 3.1% |
| Debt / equity | 0.73 |
Every AI call on HSIC since May 11, 2026, and what happened next (4 calls) →
Frequently asked questions
Is HSIC a buy? In its research of September 22, 2026, TradeFlare's AI rated HSIC a BUY. This is AI-generated research, not financial advice.
What is the price target for HSIC? The research sets a target of $91.80 with a stop at $81.31.
When was this analysis last updated? September 22, 2026. Stocks on TradeFlare's lists are re-researched every market night. How the research works.
Research of September 22, 2026 · AI-generated analysis for educational purposes, can be wrong, not financial advice.